// App-Quantinova.ai

1731 : The Myelofibrosis Symptom Burden (MF-SB): An International Phenotypic Cluster Analysis of 329 Patients

Researchers

Presenter

  • Amylou C. Dueck

Principal Investigators

  • Dolores Hernandez-Maraver

  • Heike Pahl

  • Martin Griesshammer

  • Frank Stegelmann

  • Konstanze Doehner

  • Francoise Boyer

  • Gabriel Etienne

  • Jean-Christophe Lanotto

  • Dana Ranta

  • Lydia Roy

  • Jean-Jacques Kiladjian

  • Jean-Yves Cahn

  • Claire N Harrison

  • Deepti H Radia

  • Pablo J. Muxi

  • Norman I. Maldonado

  • Carlos Besses

  • Francisco Cervantes

  • Peter Johansson

  • Giovanni Barosi

  • Alessandro M. Vannucchi

  • Stefanie Slot

  • Sonja Zweegman

  • Peter Boekhorst

  • Suzan Commandeur

  • Harry C Schouten

  • Federico Sackmann

  • Ana Kerguelen Fuentes

Medical Centers

  • Schwerpunkt Hamatologie-Onkologie-Palliativmedizin, Johannes Wesling Klinikum Minden, Minden, Germany

  • Hopital Saint-Louis and Universite Paris Diderot, Paris, France

  • III. Medizinische Klinik, Hamatologie und Onkologie, Universitatsmedizin Mannheim, Mannheim, Germany

  • Department of Medicine, Hematology and Coagulation Section, Gothenburg, Sweden

  • Internal Medicine, NU Hospital Organization, Uddevalla, Sweden

  • Department of radiology, LUMC, Leiden, Netherlands

  • Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain

  • CHU de Poitiers et INSERM CIC 802, Poitiers University Hospital, Poitiers, France

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Neurology, Mayo Clinic, Scottsdale, AZ

  • Haematology, University Hospital, Basel, Switzerland

  • Dept. of Hematology, University Hospital, Lund, Sweden

  • Policlinico S. Matteo Foundation, Pavia, Italy

  • Department of Hematology, Nancy University Hospital, Vandoeuvre-Les-Nancy, France

  • Erasmus MC, Rotterdam, Netherlands

  • Department of Haematology,, University Hospital La Paz, Madrid, Spain

  • Institute of Hematology & Institut Bergonie, Bordeaux, France

  • Medical Oncology, Hospital del Mar, Barcelona, Spain

  • Ospedali Riuniti di Bergamo, Bergamo, Italy

  • Unidadde Hematologia, Hospital Britanico, Montevideo, Uruguay

  • Dermatology, CHU of Grenoble, Grenoble, France

  • , Tianjin, China

  • Hematology, Fundaleu, Buenos Aires, Argentina

  • Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands

  • Division of Hematology, Ospedali Riuniti, Bergamo, Italy

  • Department of Medical Oncology, Guys and St Thomas NHS Foundation Trust, London, United Kingdom

Locations

  • China

  • Argentina

  • Italy

  • Netherlands

  • Germany

  • Spain

  • United Kingdom

  • Switzerland

  • Uruguay

  • United States

  • France

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Myeloid neoplasms

  • Thrombocytopenia

  • Myelofibrosis

  • Venous thrombosis

  • Insomnia

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • single ascending dose

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved